DermaPharm A/S Warning Letter Details

Summary

Based on limited metadata, DermaPharm A/S, a drug manufacturer, received an FDA Warning Letter on March 10, 2020. Without access to the full letter text or detailed subject information, the specific nature of the violations cannot be determined from the available metadata. The warning pertains to drug products under FDA jurisdiction, though the specific issuing office and violation count are not documented in the metadata provided.